Abreos Biosciences Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 6


  • Latest Deal Type
  • M&A

Abreos Biosciences General Information


Developer of peptide antigen mimetics technology designed to improve the development and commercialization of biopharmaceuticals. The company's platform are laboratory-based and point-of-care assays that enable precision dosing and counterfeit detection of biologic drugs as well as permits for direct monitoring of blood concentrations of monoclonal antibody drugs for dosage.

Contact Information

Ownership Status
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Drug Delivery
Corporate Office
  • 2223 Avenida de la Playa
  • Suite 206
  • La Jolla, CA 92037
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Abreos Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Merger/Acquisition 25-Jan-2021 00.000 Completed Generating Revenue
8. Seed Round 15-Sep-2020 00.000 00.000 Completed Generating Revenue
7. Grant 25-Feb-2020 00.000 00.000 Completed Generating Revenue
6. Accelerator/Incubator 01-Jun-2017 00.000 Completed Generating Revenue
5. Seed Round 28-Jun-2016 00.000 00.000 Completed Generating Revenue
4. Seed Round 29-Mar-2016 000 Cancelled Generating Revenue
3. Grant 25-Sep-2015 00.000 Completed Generating Revenue
2. Grant 23-Sep-2014 $371K Completed Generating Revenue
1. Accelerator/Incubator 01-Jan-2014 Completed Generating Revenue
To view Abreos Biosciences’s complete valuation and funding history, request access »

Abreos Biosciences Comparisons

HQ Location
Total Raised
Post Valuation
Developer of peptide antigen mimetics technology designed to improve the development and commercialization of biopharmac
La Jolla, CA
6 As of 2020
000000&0 00.000


veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo
Rosemont, IL
000 As of 0000
000000000 -


erit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur s
0000 000000000
San Diego, CA
000 As of 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Abreos Biosciences Competitors (13)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Proteintech Corporation Rosemont, IL 000 000000000 -
Vividion Therapeutics Formerly VC-backed San Diego, CA 000 00000 00000000
Lycia Therapeutics Venture Capital-Backed South San Francisco, CA 00 00000 00000000000 00000
ProSci (Poway) Private Equity-Backed Poway, CA 00 000000000000
Cytovance Biologics Formerly PE-Backed Oklahoma City, OK 000 0000 000000&0 0000
You’re viewing 5 of 13 competitors. Get the full list »

Abreos Biosciences Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Abreos Biosciences Former Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Blackbird Ventures (La Jolla) Venture Capital Minority 000 0000 000000 0
CONNECT (Accelerator) Accelerator/Incubator Minority 000 0000 000000 0
Keshif Ventures Venture Capital Minority 000 0000 000000 0
MedTech Innovator Accelerator/Incubator 000 0000 000000 0
National Institutes of Health Government 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »

Abreos Biosciences Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
AegirBio 27-Nov-2019 00000 0000 Monitoring Equipment
To view Abreos Biosciences’s complete investments history, request access »

Abreos Biosciences FAQs

  • When was Abreos Biosciences founded?

    Abreos Biosciences was founded in 2013.

  • Who is the founder of Abreos Biosciences?

    Thomas Kipps Ph.D and Bradley Messmer Ph.D are the founders of Abreos Biosciences.

  • Where is Abreos Biosciences headquartered?

    Abreos Biosciences is headquartered in La Jolla, CA.

  • What is the size of Abreos Biosciences?

    Abreos Biosciences has 6 total employees.

  • What industry is Abreos Biosciences in?

    Abreos Biosciences’s primary industry is Biotechnology.

  • Is Abreos Biosciences a private or public company?

    Abreos Biosciences is a Private company.

  • What is Abreos Biosciences’s current revenue?

    The current revenue for Abreos Biosciences is 000000.

  • How much funding has Abreos Biosciences raised over time?

    Abreos Biosciences has raised $8.44M.

  • Who are Abreos Biosciences’s investors?

    Blackbird Ventures (La Jolla), CONNECT (Accelerator), Keshif Ventures, MedTech Innovator, and National Institutes of Health are 5 of 9 investors who have invested in Abreos Biosciences.

  • Who are Abreos Biosciences’s competitors?

    Proteintech, Vividion Therapeutics, Lycia Therapeutics, ProSci (Poway), and Cytovance Biologics are some of the 13 competitors of Abreos Biosciences.

  • When was Abreos Biosciences acquired?

    Abreos Biosciences was acquired on 25-Jan-2021.

  • Who acquired Abreos Biosciences?

    Abreos Biosciences was acquired by AegirBio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »